Hesperos, Inc. is a global contract research organization (CRO) providing compound safety and efficacy testing services using its Human-on-a-Chip® platform – an advanced, multi-organ microphysiological system. Hesperos’ Human-on-a-Chip is used by pharmaceutical, cosmetic, and government entities to better understand specific disease states and the human response to therapeutics. The flexible platform can be configured depending on the application, such as: reproducing (and treating) specific disease states, evaluating various drug delivery methods (IV, oral, topical), and investigating both the acute and chronic effects of a given compound or combination.